Current Status of Pancreas Transplantation

Gaetano Ciancio, Junichiro Sageshima, Linda Chen, Alberto Pugliese, George W. Burke

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations


Transplantation of whole pancreas can restore euglycemia in patients with insulin-dependent, type 1 diabetes (T1D). It reverses diabetes in most patients, improving complications and quality of life, but requires chronic immunosuppression. Given the side effects and health risks associated with immunosuppression, exogenous insulin therapy remains the mainstay of treatment for most patients with T1D, unless patients cannot adequately control their metabolism with exogenous insulin or develop life-threatening complications (such as severe hypoglycemia and kidney failure) that can be corrected by transplantation. Pancreas transplantation (PT) is presently associated with excellent graft survival and function but requires surgery with the risk of perioperative mortality and morbidity. Thus, clinical indications and patient selection are very important. Patients with end-stage renal disease are candidates for simultaneous kidney-pancreas transplantation, which accounts for the majority of pancreas transplants. This chapter will review the current status of PT and discuss major challenges and future directions.

Original languageEnglish (US)
Title of host publicationRegenerative Medicine Applications in Organ Transplantation
PublisherElsevier Inc.
Number of pages8
ISBN (Print)9780123985231
StatePublished - Jan 1 2014
Externally publishedYes


  • Autoimmunity
  • Immunosuppression
  • Pancreas transplantation
  • Rejection
  • Type 1 diabetes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Current Status of Pancreas Transplantation'. Together they form a unique fingerprint.

Cite this